Carmell CorporationCarmell CorporationCarmell Corporation

Carmell Corporation

No trades
See on Supercharts

Key stats

Market capitalization
‪42.50 M‬USD
Dividend yield (indicated)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
Net income (FY)
Revenue (FY)
Shares float
Beta (1Y)
2.66

About Carmell Corporation

CEO
Rajiv Sarman Shukla
Headquarters
Pittsburgh
Founded
2008
FIGI
BBG00ZNQBGG4
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.